These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 30439465)

  • 21. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
    Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
    Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
    Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
    United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study.
    Goedert JJ; Gong Y; Hua X; Zhong H; He Y; Peng P; Yu G; Wang W; Ravel J; Shi J; Zheng Y
    EBioMedicine; 2015 Jun; 2(6):597-603. PubMed ID: 26288821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
    Xie YH; Gao QY; Cai GX; Sun XM; Sun XM; Zou TH; Chen HM; Yu SY; Qiu YW; Gu WQ; Chen XY; Cui Y; Sun D; Liu ZJ; Cai SJ; Xu J; Chen YX; Fang JY
    EBioMedicine; 2017 Nov; 25():32-40. PubMed ID: 29033369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moderate alteration to gut microbiota brought by colorectal adenoma resection.
    Yu SY; Xie YH; Qiu YW; Chen YX; Fang JY
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1758-1765. PubMed ID: 31115072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
    Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
    Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients.
    Khodaverdi N; Zeighami H; Jalilvand A; Haghi F; Hesami N
    BMC Cancer; 2021 Dec; 21(1):1353. PubMed ID: 34937552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort.
    Bond AD; Burkitt MD; Sawbridge D; Corfe BM; Probert CS
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):71-7. PubMed ID: 27014756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiome: New biomarkers in early screening of colorectal cancer.
    Zhou P; Yang D; Sun D; Zhou Y
    J Clin Lab Anal; 2022 May; 36(5):e24359. PubMed ID: 35312122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
    Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
    Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.
    Rozen P; Comaneshter D; Levi Z; Hazazi R; Vilkin A; Maoz E; Birkenfeld S; Niv Y
    Cancer; 2010 May; 116(9):2115-25. PubMed ID: 20186820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the predictive performance of gut microbiota for the early-stage colorectal cancer.
    Amini M; Rezasoltani S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR
    BMC Gastroenterol; 2022 Dec; 22(1):514. PubMed ID: 36510191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shifts in the Fecal Microbiota Associated with Adenomatous Polyps.
    Hale VL; Chen J; Johnson S; Harrington SC; Yab TC; Smyrk TC; Nelson H; Boardman LA; Druliner BR; Levin TR; Rex DK; Ahnen DJ; Lance P; Ahlquist DA; Chia N
    Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):85-94. PubMed ID: 27672054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.
    Bond A; Greenwood R; Lewis S; Corfe B; Sarkar S; O'Toole P; Rooney P; Burkitt M; Hold G; Probert C
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1005-1012. PubMed ID: 30828825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants.
    Kværner AS; Birkeland E; Bucher-Johannessen C; Vinberg E; Nordby JI; Kangas H; Bemanian V; Ellonen P; Botteri E; Natvig E; Rognes T; Hovig E; Lyle R; Ambur OH; de Vos WM; Bultman S; Hjartåker A; Landberg R; Song M; Blix HS; Ursin G; Randel KR; de Lange T; Hoff G; Holme Ø; Berstad P; Rounge TB
    BMC Cancer; 2021 Aug; 21(1):930. PubMed ID: 34407780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationships between the enrichment of ETBF, Fn, Hp in intestinal and colorectal cancer].
    Zhang J; Lu XL; Zhao G; Shi HT; Geng Y; Zhong WT; Dong L
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):99-104. PubMed ID: 29502368
    [No Abstract]   [Full Text] [Related]  

  • 38. Fecal metabolomic profiles: A comparative study of patients with colorectal cancer
    Nannini G; Meoni G; Tenori L; Ringressi MN; Taddei A; Niccolai E; Baldi S; Russo E; Luchinat C; Amedei A
    World J Gastroenterol; 2021 Oct; 27(38):6430-6441. PubMed ID: 34720532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of oncogenic bacteria with colorectal cancer in South China.
    Zhou Y; He H; Xu H; Li Y; Li Z; Du Y; He J; Zhou Y; Wang H; Nie Y
    Oncotarget; 2016 Dec; 7(49):80794-80802. PubMed ID: 27821805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.